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ABSTRACT 
 
A novel inherited retinal disease, pigmentary chorioretinopathy, has been observed in one of the 
oldest purebred breed, Chinese crested. Two forms of progressive retinal atrophy (PRA), 
Progressive rod con degeneration (prcd) and one other form with unknown genetic basis, has 
already been observed in the breed. This novel retinopathy showed clinical features of progressive 
nature with bilateral degeneration, migration of lesions from tapetal to non-tapetal and central area 
in fundus and end stage leading to blindness. A distinct feature of primary defect in retinal 
pigment epithelium differentiates this disease from PRA. A genome-wide association study with 
170K Illumina CanineHD SNP chip was performed using 19 cases and 21 controls. After 
correcting for population stratification, applying a combined approach of Mixed model and 
Structured association in R (GenABEL package), an association analysis using 14 cases and 21 
controls resulted in a stronge association with two SNPs (P-raw: 4.59e-06 and 5.74e-06) located 
around 300 kb apart, on chromosome 8. After further analysis in Ensembl (CanFam 2.0), we 
found that one of the SNPs was located in an intronic sequence of the gene MDGA2 (MAM 
domain containing glycosylphosphatidylinostitol anchor 2 - 371.42 kb) and the other was located 
downstream to this gene. MDGA2 is a member of the immunoglobulin superfamily class 
(IgCAM) and is involved in cell adhesion, migration and recruitment to inflammatory sites. 
Sequencing of the coding region of MDGA2 revealed a non-synonymous mutation that caused an 
amino acid shift from “threonine” to “serine”. The sequence analysis was inconclusive; hence 
more individuals need to be sequenced for a definite conclusion. Also, a manual gene annotation 
of MDGA2 is required for a mutation to be concluded as not causative. Hence, additional studies 
need to be performed to unravel the genetic basis of the disease which will guide us to the 
possible preventing strategy in near future. 
 
Keywords: Retinopathy, Retinal disease, Genome wide association study, Chinese crested,  
                  Pigmentary chorioretinopathy, Retinal pigment epithelium (RPE) 
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INTRODUCTION 
 
  
Man’s best friend, the domestic dog has proven to be a valuable model for investigating the 
genetic basis underlying canine and human diseases (Karlsson and Lindblad-Toh, 2008). Humans 
and dogs share common physiological traits, have often similar clinical responses, similar disease 
presentation and also live in the same environment as humans do. The domestic dog has gone 
through several bottlenecks. The first bottleneck occurred during the domestication from wolves 
around 7,000 -50,000 generations ago (Lindblad-Toh et al., 2005).  The establishment of dog 
breeds in the mid 1800s has led to further loss of genetic variation in each breed and has resulted 
in unique features and breed-specific phenotypes. This has caused increased risk for developing a 
variety of genetic diseases, some that appears to be breed-specific.  
 
Canine Inherited Eye Diseases: 
The number of reported hereditary disorders in domestic dogs exceeds 400 (Giger et al., 2006). 
With the advancement in genetic approaches and the development of molecular genetic tools and 
approaches to identify underlying causative loci for a disease, this number has further been 
increasing. To this date, 24 mutations in 18 genes underlying retinal diseases (retinopathy) in at 
least 58 dog breeds have been identified (Miyadera et al., 2012a). 
Retina in dogs is undeveloped at birth and matures at 3-6 weeks after birth, but the structure of 
developed retina in dogs is similar to retina in human (Miyadera et al., 2012b). The retina is a 
neuronal portion of the eye. The retina consist of five different neuronal cell layers: 
photoreceptors (rods and cones) located in the outer nuclear layer (ONL), bipolar cells, horizontal 
cells and amacrine cells located in the inner nuclear layer (INL) and the innermost cell layer of 
ganglion cells (Doh et al., 2010). 
   
Figure 1 Retinal layers (from http://eyesee-eyetalk.blogspot.se/2007/12/231-worn-and-torn-
retina.html). To the left is the sketch of dog eye with general anatomy. The right picture gives a view 
of different cell layers that describes retina. 
 
 
The photoreceptor cells are: rods (vision for dark and dim light) and cones (vision for day light 
and colour). The rods are present in large numbers compared to cones in both humans and dogs. 
The photoreceptor layer is further divided into outer segment (OS), which lies close to the 
pigment epithelium and consist of a membranous disk, and inner segment (IS) that consists of cell 
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nuclei. The bipolar, horizontal and amacrine cells are retinal neurons responsible for lateral 
interactions from photoreceptor cells to the ganglion cells (Purves et al., 2001). The information is 
transferred from photoreceptor cells to bipolar cells to ganglion cells which transfer the 
information to the optic nerve. 
The retinal pigment epithelium (RPE) is a cell monolayer that contains melanin that reduces the 
backscattering of the lights and acts as a barrier between choroid and the photoreceptor cells 
(Purves et al., 2001). RPE cells are involved in retinoid cycle in regeneration of the light 
absorbing chromophore (11-cis-retinal). Also, RPE cells participates in degradation and recycling 
of rods and cones in outer segments through phagocytosis (Kuksa et al., 2003). 
 
Figure 2. Retinoid cycle (Miyadera et al., 2012a). Outer segment (OS) of photoreceptor cells contain 
Opsin (rhodopsin-rods and photopsin-cones) that is bound to 11-cis-retinal (light absorbing 
chromophore). 11-cis-retinal is converted to all-trans-retinal by light (photon) that initiates 
phototransduction cycle (light stimuli is converted into chemical signals). All-trans-retinal is 
converted to all-trans-retinol and transported to RPE. Esterification and oxidization process convert 
all-trans-retinol to 11-cis-retinal that binds to opsin in outer segment ready to begin next cycle. 
 
Inherited retinal diseases can be classified as progressive, stationary and developmental (Miyadera 
et al., 2012a). Inherited progressive disorders primarily affect photoreceptor cells, show 
progressive ophthalmoscopic degenerative changes with variable rate and is breed specific. 
Progressive retinal atrophy (PRA) and Cone rod dystrophy (CRD) are examples of inherited 
progressive disorders. Stationary retinal disorder shows very slow progression or non progressive 
abnormalities after the initial diagnosis of the disease. Achromatopsia (cone degeneration, 
hemeralopia), canine Leber congenital amaurosis LCA (congenital stationary night blindness-
csnb) and retinal dystrophy are included in stationary retinal disorders. The developmental (non 
degenerative) retinal disorders include syndromic retinal dysplasia (defect in retinal 
differentiation): oculoskeletal dysplasia 1 (in Labrador retrievers) and 2 (in Samoyed), and 
asyndromic retinal dysplasia (Bedlington terriers and Labrador retrievers) with unknown genetic 
causes. It also includes Collie eye anomaly (CEA) that affects the retina-choroid-sclera complex, 
the main clinical feature being choroidal hypoplasia (under-development of choroid). 
Among many inherited retinal disorders mentioned above, PRA is a  heterogeneous disease that 
has been described in more than 100 breeds (Vilboux et al., 2008, Aguirre and Acland, 2006). 
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PRA is a group of inherited retinopathies that share general clinical ocular abnormalities and the 
primary feature being a loss of rods followed by loss of cone photoreceptors. The bilateral nature 
of PRA progresses with similar retinal changes of increase in severity on both eyes in a parallel 
way and end stage retinal atrophy leading to blindness.  
 
Pigmentary Chorioretinopathy: 
The focus of this study is to find the genetic basis of a novel inherited retinal disease that has been 
termed pigmentary chorioretinopathy in Chinese crested dog (CCD). The breed is one of the 
oldest purebred dogs and in recent years has become increasingly popular in Sweden (among the 
top 10 most popular breed in Sweden in 2010). Two different varieties of CCD can be observed: a 
hairy phenotype known as “Powder puff” or wild type and hairless (mutant) phenotype. The 
hairless phenotype in CCD has a crest of fur on head, tail and fur around the feet and this 
phenotype arise due to a monogenic autosomal semidominant trait, Canine ectodermal dysplasia 
(CED) (Narfström et al.).   
 
Earlier, progressive rod cone degeneration (prcd) mutation has been found in CCD as one of the 
two forms of PRA. The genetic basis for the other type is not known (Optigen). However, CCD 
involved in this study showed negative results for the prcd mutation (Zangerl, Goldstein et al. 
2006).  
The clinical features of pigmentary chorioretinopathy include bilateral nature of degeneration, 
appearance of lesions/pigmentation in the periphery of tapetal fundus in earlier stage that migrate 
to central and non-tapetal fundus as the disease progresses leading to blindness (Narfström et al.). 
Difference in electroretinographic responses and defects in arterio-venous phase were more 
visible in later stages of the disease. The foremost changes are observed in RPE cells that 
appeared thick and contained pigment granules. On histology, this monolayer appeared as 
degenerating multilayer in some areas. RPE cells were detached and migrated towards the outer 
segment. The phagocytosis cells and pigment granules were observed along with RPE cells in the 
outer segment. Such abnormal changes in RPE were observed before degeneration of rods and 
cones which distinguishes current retinopathy in CCD from classical PRA.  
Primary abnormal change in RPE is also an essential feature in Canine multifocal retinopathy 
(CMR) observed in a number of dog breeds such as English Mastiff, Bullmastiff, Great Pyreness 
and Coton de Tulear. Two different mutations in VMD2 gene: 73C>T stop mutation in cmr1 and 
482G>A missense mutation in cmr2 are responsible for CMR (Guziewicz et al., 2007). Inherited 
retinal dystrophy also shows primary changes in RPE layer. A homozygous 4bp deletion: 
485delAAGA in exon 5 of Rpe65 gene (encodes a microsomal protein in RPE) leadingto frame 
shift mutation has shown to cause retinal dystrophy in Swedish briard/briard-beagle dogs (Veske 
et al., 1999). The primary defect in RPE is also seen in Retinal pigment epithelial dystrophy 
(RPED) with questionable genetic basis as the features of this disease is also seen in the dogs with 
vitamin E deficiency. 
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Genome Wide Association Studies (GWAS): 
The objective of this study is to identify potential genomic loci associated with pigmentary 
chorioretinopathy with a Genome-Wide Association Study (GWAS) approach. In general, GWAS 
is used to find common causal genetic variants underlying disease through use of high density 
SNP genotyping arrays. It is based on the concept of common disease common variant (CDCV). 
Balding (2006) explains CDCV as the hypothesis that genetic variants underlying complex 
diseases are common and can be detected with current population association study designs. 
GWA study includes the benefits of linkage studies which do not need prior knowledge of 
potential region of susceptibility, and advantages of association methods that is more powerful at 
detecting genes of small effect (Dick, 2008). 
The correlation between a marker allele (single nucleotide polymorphism- SNP) and a certain 
disease is evaluated by comparison of allele or genotype frequencies among individuals in 
different kinds of study designs such as case-control, multistage and family-based design. Case-
control design is generally powerful for detecting association (Dick, 2008). This evaluation 
involves comparison of marker allele frequency between cases and controls using statistical 
methods. However, the main problem in case-control design is rise of spurious association 
(Pearson and Manolio, 2008), a significant association without any genetic effect. Many 
confounding factors such as population structure, cryptic relatedness/family structure, multiple 
testing, differential bias give rise to this problem.  
Population structure is the major confounding factor in case-control design for spurious 
association. An example of spurious association was observed between the trait height with a SNP 
in a gene LCT (lactase gene) which varies widely across European population (Campbell et al., 
2005). When the population under study includes subgroups such that individuals in subgroups 
are more related to one another on average than to other individuals in a population, such 
population is referred to as structured (Balding, 2006). Stratification may arise due to systematic 
ancestry differences and may have large impact when cases and controls are sampled from two 
different subpopulations. To overcome such circumstances the following assumptions need to be 
applied: unrelated cases and unrelated but matched controls should be drawn from same 
population (‘unrelated’ refers to the unknown relationships which is presumed to be distant), 
affected individuals are representative of all cases of the disease, genomic and epidemiologic data 
for cases and control should be collected similarly. Observed differences in allele frequencies is 
due to the outcome of certain trait of interest and not due to differences in background population 
between cases and controls (Pearson and Manolio, 2008). 
Another important issue in case-control studies is cryptic relatedness, a hidden kinship among 
cases or controls (Voight and Pritchard, 2005). Devlin and Roeder (1999) consider cryptic 
relatedness to have serious impact compared to population structure. Voight and Pritchard (2005) 
provided only certain scenarios where cryptic relatedness might have a greater impact. A greater 
impact will be observed when a small study population has been derived from the population 
which had a recent and rapid growth. Also, in a population with extensive inbreeding the 
relatedness among individuals in the study population will make GWAS approach less likely to be 
successful. In such cases, the genetic factors controlling the trait may have reached fixation in the 
population. 
The presence of confounding effects in the analysis is evaluated by calculating variance inflation 
factor “λ”. It is calculated as the median chi-square association statistic across SNPs divided by its 
theoretical median under null distribution (Price et al., 2010). λ >1 indicates stratification or 
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presence of any other confounding effects, λ ~ 1 (approximately) indicates absence of any 
confounding factors. Also, λ is proportional to the sample size.  
The basic association test to search for the potential genomic loci associated with the disease 
includes a chi-square test based on 2*2 contingency table of allele counts or 2*3 contingency 
table of genotype counts for case and control group. The relative frequency of allele or genotype 
is expected to be same in the case and control groups under the null hypothesis (no association). 
The independence of rows and columns in a contingency table is evaluated by chi-square test 
(Clarke et al., 2011). 
Approaches such as structured association and principal component analysis (PCA) infer genetic 
ancestry and accounts for population stratification. In structured association, cluster-based 
algorithm is applied to group participants and association statistic is calculated by stratifying the 
sample population by clusters. Computer software like STRUCTURE is used for allocation of 
individuals into different subpopulation and association test is performed via program as STRAT 
(Price et al., 2010). The number of clusters to be assigned to a population has always been a major 
limitation (Setakis et al., 2006).  Unlike, computationally challenging structured association, PCA 
corrects for stratification using top principal components (eigen vectors) as the covariates (Price et 
al., 2010). In both approaches, the markers with strongly differentiated allele frequencies are 
corrected with a greater value. According to Price, Zaitlen et al. (2010), above mentioned 
approaches do not correct for other confounding factors such as family structure or cryptic 
relatedness. 
An alternative method is the “genomic control” which corrects for both stratification and cryptic 
relatedness (Devlin and Roeder, 1999). As it is based on a Bayesian probability model, it does not 
apply the traditional methods of correction for multiple testing (e.g. Bonferroni correction). An 
association statistic Y2 is adjusted at each position by uniform overall inflation factor, λ. “Y2/λ” is 
used at individual marker instead of Y2. Such correction might not be sufficient for markers that 
have greater difference in allele frequencies across the ancestral population whereas the correction 
might be unnecessary for markers that have very limited difference in allele frequency which 
leads to loss of power (Price et al., 2006).  
Genomic control, Structured based association and PCA approach are based on the following 
general linear model, 
       
Where, Y is the phenotype, X is the genotype at the candidate marker. Additional co-variates can 
also be added to X. B denotes the coefficient of fixed effects (markers and other co-variates) and 
‘e’, the residual denotes the variation in Y unexplained by the fixed effects taken into 
consideration. 
 
In a PCA approach, the principal components are included in X as the co-variates that take into 
account the fixed effects of genetic ancestry (Price et al., 2010). 
 
Mixed Linear Model (MLM) approach can successfully model population structure, family 
structure and cryptic relatedness [(Price et al., 2010),(Yu et al., 2006)].  
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Y denotes a vector of phenotype, v and B denotes the unknown fixed effects of marker and non-
marker effect respectively. ‘u’ denotes vector of unknown random polygenic effects and ‘e’ 
denotes a vector of residual effect. W, X and Z are the incidence matrices. Here, variance of the 
random polygenic effects,           , 
where, ‘K’ denotes a kinship matrix which is calculated on the basis of pedigree information or 
the genetic markers. To derive kinship matrix from the genetic markers, pairwise identity by state 
(IBS) is calculated among individuals. IBS is computationally tractable without prior knowledge 
of allele frequencies or pedigree information with less impact of population stratification 
(Roberson and Pevsner, 2009). IBS for a pair of individuals ‘i’ and ‘j’ is computed by: 
        
                 
           
 
where, k=number of SNPs,      is the genotype of ith individual at k
th SNP and      is the 
genotype of jth individual at kth SNP coded as 0, ½ and 1,    is the frequency of the “+” allele. ‘e’ 
is a vector of random residual effect which has zero mean and covariance      
   where,   is the 
identity matrix and   
  is the unknown residual variance. The evaluation is done on each marker 
with the null hypothesis of v=0 and alternative hypothesis of v 0. The maximum likelihood 
estimation is performed and the test of null hypothesis is done using F-statistic or chi-square test. 
 
Figure 3. Application of different approaches during presence of different levels of  population 
structure and familial relatedness in the study sample (Aulchenko, 2010). Combined use of mixed 
model and structured association is appropriate when the study population has both high level of 
relatedness and population structure. Mixed model approach is suitable when the study population is 
less effected by population structure but has high level of relatedness. In contrast, use of structured 
association is effective when the study population has less relatedness but high population structure. 
Genomic control is effective when there is presence of less relatedness and population structure. 
 
Another problem in GWA study is multiple testing which imposes a risk of large number of the 
markers being associated with the disease phenotype falsely or by chance alone. In order to 
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overcome such scenarios various correction methods are applied but till date Bonferroni 
correction is the most commonly used method (Balding, 2006). The level of significance is 
divided by the number of multiple tests performed calculating a value. The p-value for a test 
should be less than the level of significance obtained after Bonferroni correction for any 
association to be taken as significant. Another procedure, permutation testing is also used to 
correct for multiple testing. Here, the case-control labels among the study samples are changed 
randomly for a specified times and the original tests is repeated for specified times. The empirical 
P-values thus obtained are compared with the original P-value. Although computationally 
intensive, this approach is considered as a “gold standard” for accurate correction (Clarke et al., 
2011). 
Various genetic analysis tools have been developed for association studies. Each tool comprises 
different approaches which can be used on the basis of presence of confounding factors in the 
study samples. PLINK, STRUCTURE, EIGENSTRAT, EMMAX are some of the tools set for 
GWAS (Clarke et al., 2011, Price et al., 2010). 
‘GenABEL’ (package for genome-wide association analysis between quantitative or binary traits 
and SNPs) in R-program (www.r-project.org) open statistical analysis software has been used for 
GWA in the case control design study of CCD. Different methods of association analysis such as 
Basic association test, Genomic control, structured association, PCA and Mixed models are 
included in the GenABEL-package (Kierczak et al., 2011). For GWAS in case-control design of 
CCD, association analyses have been performed using all the models mentioned above. 
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MATERIALS AND METHODS 
 
Materials 
Sample collection: 
The sample comprised of 40 dogs (Table 1). The information regarding age of onset of disease, 
gender and age of controls have been collected from Swedish Kennel Club- SKK (www.skk.se). 
Age at diagnosis in the 19 cases varies from ~3 to ~10 years. The age at examination for the 21 
controls ranges from ~4 to ~11 years. 26 individuals belonged to Powder Puff variant and 14 
others couldn’t be identified. The majority of individuals (25) were Swedish, second largest group 
(10) are from Finland and remaining individuals are from Germany and USA. To ensure 
consistent phenotype classification, the majority of dogs were examined by the same specialist in 
Veterinary Opthalmology (prof Kristina Narfström). Blood samples were collected from both 
cases and controls into EDTA tubes and genomic DNA was extracted from peripheral blood 
leukocytes using a QIAsymphony SP/AS instrument (Qiagen, Hilden, Germany). 
 
Table 1 The sample population divided on the basis of phenotypic status, gender and country of origin. 
Country of 
origin 
Cases Controls 
Total 
Male Female Total Male Female Total 
Sweden 6 5 11 10 4 14 25 
Finland 3 2 5 3 2 5 10 
Germany 1 - 1 - 2 2 3 
USA - 2 2 - - - 2 
Total 10 9 19 13 8 21 40 
  
SNP Array: 
The long Linkage disequilibrium (LD) regions in dogs at around 500 Kb to 1 Mb (Karlsson et al., 
2007) gives an opportunity to use few SNPs for whole genome coverage for association analysis. 
CanineHD Beadchip from illumina was used for the study. The array includes SNPs derived from 
2.5 million SNP set of Dog Genome Project (CanFam 2.0) and 1, 696 SNPs that have been 
identified using hybridization-based targeted re-sequencing method. CanFam 2.0 assembly is built 
on the basis of a whole genome shotgun (WGS) sequencing of the Boxer and partial sequence of a 
Poodle (REF) and 100 000 sequence reads from nine different breeds. More than 170 000 evenly 
spaced SNPs with an average of > 70 SNPs per megabase (Mb) are present on the array. 
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Figure 4 The frequency of different length of distance between SNP markers. The distance of 10-
14 kb between markers is observed in high frequency in the array. 
 
Pedigree 
The records from SKK were used to build a pedigree of. The registration ID of each individual in 
the study sample was entered in SKK website and the relationships were obtained. The ancestors 
of the individuals were traced back for two to three generations. The age of onset for the cases and 
age at which the controls had last been examined for eye disease is noted in the pedigrees. Firstly, 
the relationship among the cases and controls were investigated through pedigree. Later the cases 
were further followed (traced forward to find the offsprings) to understand the mode of 
inheritance of the disease.  
 
GWA Study: 
40 CCD dogs were genotyped with the CanineHD Beadchip at GeneSeek 
(http://www.neogen.com/GeneSeek/). The genotyping results from GeneSeek were in Plink 
format (ped- and map files) and were then converted into a format required by GenABEL. A 
separate file “phenotype.dat” was created to provide phenotypic information: sex and disease 
status of studied individuals. 
 
Quality control: 
174357 markers were genotyped/ called for 40 individuals. The quality of data plays important 
role and have a significant impact on association analysis hence, should be edited correctly. 
Therefore, in a preliminary quality control procedure both markers and individuals were analysed 
on the basis of genotyping rate (< 95% removed) In the next step, individuals were analysed on 
the basis of autosomal heterozygosity (False Discovery rate < 1%) and value of IBS ( >= 0.95 
removed) between individuals. The markers were further analysed for minor allele frequency 
(MAF) where markers with a threshold of < 1 10-08 were considered as non-informative and were 
removed. P-value for Hardy-Weinberg Equilibrium (HWE) is the probability that the deviation of 
the marker from HWE is explained by the chance (Purcell et al., 2007). The markers deviating 
from HWE with p-value of < 1 10-08 were removed carefully as the selection, inbreeding, 
population stratification and also disease association could have lead to the deviation (Balding, 
2006). 42564 markers were removed on the basis of call rate and MAF threshold. 480 markers 
were removed on the basis of HWE criterion. 130308 remaining markers and all 40 individuals 
passed the criteria.  
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Classical Multi-dimensional Scaling Plot (MDS): 
To build a kinship matrix based on the genetic markers, only the autosomal markers were used to 
calculate IBS between the individuals. A 40*40 genomic kinship matrix can also be used as a 
quality control step where very closely related individuals could be removed based on the value of 
IBS. A distance matrix is built from the genomic kinship matrix that was used to make a classical 
Multi-Dimensional Scaling (MDS) plot. A MDS plot is constructed to map all pair wise distances 
into k-dimensional space such that the distance between the individuals in the plot is closest to the 
real distance in the distance matrix. The primary purpose of MDS plot is to visualize population 
substructure (Purcell et al., 2007). However, k-dimensional representation of the substructure 
obtained from MDS can also be used as a covariate in association analysis. Also, the classical 
MDS obtained using Euclidean distance metric is numerically identical to PCA.   
 
5 out of 19 cases considered as outliers on the basis of MDS plot were removed and further steps 
were performed with 14 cases and 21 controls (35 individuals).  
 
Final quality control: 
The individuals and markers were further analysed on basis of genotyping rate (< 95% removed) 
and markers with a minor allele frequency (MAF) of less than 5% were removed. HWE was 
applied only to the controls. FDR of 0.2 is set due to negative value in HWE. 19 596 markers 
were removed on the basis of genotyping rate and MAF threshold. 358 markers were removed on 
the basis of HWE threshold. 110 409 markers passed the final quality controls out of which 107 
862 autosomal markers were used for MDS plot.  
Clustering (K-means): 
The individuals were clustered through K-means clustering method (Kierczak et al., 2011). 10 
different clusters were built. To determine the optimal number of subpopulations that the total 
population could be divided in, within group sum of squares (WSS) was plotted against the 
number of clusters. Guided by the plot (WSS vs K), the population was divided into 3, 4 and 5 
clusters and association analyses were performed taking these cluster into account. The clustering 
of individuals was performed through the nearest mean clustering method. In the classical MDS 
plot, the distance is calculated using Euclidean distance method. 
 
Association Analysis: 
Fisher’s exact test was performed in GenABEL to analyse if there is significant association of 
“sex” variable with disease phenotype. P-value of 0.175 was observed for 35 individuals, 
suggesting a non significant association between the variable “sex” and “disease” phenotypes. 
Hence, this variable was not included in the association analysis as a covariate. 
GWA study was carried out using six different models:  
 Basic association test 
 Genomic control 
 Structured association: grouping individuals into 3, 4 and 5 different clusters. 
 Principal component analysis 
 Mixed model approach, and  
 A combined approach of mixed model and structured association: 3, 4 and 5 different 
clusters. 
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The level of significance for multiple testing was obtained with Bonferroni correction by dividing 
a p-value=0.05 with the total number of multiple tests performed. The significant value for a test 
after Bonferroni correction was 4.52x10-07. 
Regardless of model used, the strongest association of the disease phenotype was found to SNPs 
on a region of chromosome 8. Two SNPs “BICF2P713861” and “TIGRP2P110467” were located 
at position 26769490 and 27113849 on chromosome 8, respectively. This held true despite that fact 
that different values of inflation factor λ was obtained from different models.  
 
Visualization of Linkage Disequilibrium (LD) on chromosome 8: 
Haploview, an open source program written in Java (Barrett, 2009), helps to visualise the 
haplotype block built on the basis of pair wise LD between the markers. This plot helps to identify 
if associated SNPs are present in the haplotype block such that association analysis taking 
haplotype into account can also be performed. 
 
The pair wise LD among the markers on chromosome 8 was calculated from Haploview (version 
4.0). Linkage disequilibrium denotes a non-random association between alleles such that those 
alleles appear more often than by chance. The files were loaded in linkage format: “ped” file and 
“info” file. The markers on chromosome 8 were filtered according to the threshold of p-value=1e-
06 for HWE, <75% genotyping rate and MAF=1x10-03. Pairwise LD was measured as “r2” for the 
markers within a distance of 500kb.”r2” is based on the correlation of marker alleles. The value 
extends from 0 to 1 (0 < r2 < 1).  
 
The genotypes of the individuals for the markers from position “26675235” to “27139726” was 
analysed to search for the haplotype block segregating differently in cases and controls which 
helps to narrow down the region to look for the casual variant (Downs et al., 2011). 
Odds Ratio: 
Allelic odds ratio are generally used to analyse the association of the marker with disease 
phenotype in association studies with SNPs (Sato et al., 2006). With this concept, the odds ratio 
for the potential risk allele was calculated using VassarStats 
(http://faculty.vassar.edu/lowry/VassarStats.html). Yates values were used and were corrected for 
continuity. 
Sequencing of coding region: 
The positions of the markers with strongest association were investigated in the Ensembl genome 
database (http://www.ensembl.org/) derived from CanFam 2.0 assembly that linked to a gene 
MDGA2/ MAMDC1 (MAM-domain containing glycosylphosphatidylinositol anchor 2) of 317.42 
kb. All 15 exons of MDGA2 gene were sequenced. This procedure was performed to search for 
any non-synonymous mutations in MDGA2 gene between cases and controls in the study sample.  
 
Figure 5 The image exported from Ensembl (CanFam 2.0) gives an overview of the location of gene 
MDGA2 on chromosome 8.  
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Figure 6 The transcript of MDGA2, that contains 15 exons. The position “26,840,418” and 
“27,137,834” are the last and first position in base pair, respectively of the transcript that is 297.42 
kb long. Out of two strongly associated SNPs, “TIGRP2P110467” is located on Intron 2-3 and 
another SNP “BICF2P713861” is located outside the transcript ~70 kb downstream. 
 
The primers were designed through PrimerZ ( http://genepipe.ncgm.sinica.edu.tw/primerz ), a 
web application that designs exon-primers (Tsai et al., 2007) based on the annotation of a specific 
gene in Ensembl gene ID (ENSCAFG00000014164). PrimerZ generated 20 different primer pairs 
that covered all exons 14 exons of MDGA2 and a xx bp portion of the the 3’-UTR and 5’-UTR 
regions. All primers were designed with M13 forward (-21) or reverse (-29) tails included for 
direct sequencing. The primers pairs are listed under Primer section of Appendix. 
 
Polymerase Chain Reaction (PCR) and Sequencing: 
Big Dye Direct Cycle Sequencing Kit (www.appliedbiosystems.com) was used for PCR 
amplification and sequencing of PCR product.  
 
5 µl of PCR amplification master mix, 1.5 µl of ~0.8 µM of M13 tailed primer pairs (forward and 
reverse), 1 µl of ~4ng/ µl concentration of genomic DNA and 2.5 µl of deionised water were 
mixed for PCR amplification. This final volume of 10 µl was amplified with PCR program: 95oC 
for 15 min followed by 25 cycles of initial denaturation of 95oC for 1 min, annealing of 58oC for 1 
min and elongation of 72oC for 1 min, followed by final elongation temperature of 72oC for 7 
min.  
Gel electrophoresis was performed by loading ~1 µl of PCR product and ~2 µl of Loading Buffer 
into 2% of agarose gel. The size of the bands was confirmed by use of a ladder of 50 – 2,000 bp .   
Sequencing of PCR products was performed by adding 1 µl of Big Dye Direct M13 forward or 
reverse primer and 2 µl of Big Dye Direct sequencing master mix into each well. Sequencing 
program was performed with GeneAmpTM PCR System 9700 thermal cycler (Applied 
Biosystems) and included three holding steps: 37oC for 15 min, 80oC for 2min, 96 oC for 1min 
followed by 25 cycles of initial denaturation temperature 96oC for 10sec, annealing temperature 
50oC for 5sec and elongation temperature 60oC for 4 min. The sequenced products were held at 
4oC until purification that was done using Big-dye X TerminatorTM purification kit.  A mixture of 
45 µl of SAM solution and 10 µl of BAM solution was added to each sequenced product (well). 
The mixture is vortexed using IKA MS3 Digital Vortexer at speed of 2000 rpm for ~20 mins. The 
solutions was centrifuged using a swinging bucket centrifuge for 2 mins at 1000*g and analysed 
using capillary electrophoresis. 
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Capillary electrophoresis was performed on 3500XL Genetic Analyzer (Applied Biosystems) with 
Dye Set Z, POP-7TM polymer, 50 cm array and Big dye direct seq_3.1_pop_7X_term as run 
module. Initially, only one case and one control were sequenced using all 20 primer pairs. The 
difference was observed in some areas. Hence, other four samples from control and four samples 
from cases were sequenced for region of promoter, exon 6 and 15. 
 
Sequence Analysis: 
The sequence alignment software Codon Code Aligner (version 4.0.2, CodonCode Corporation) 
was used to analyse the chromatogram files (sequences) of exons to find for any changes in the 
nucleotides between cases and controls. The sequence from Ensembl was taken as the consensus 
/reference sequence based on which both forward and reversed sequences of cases and controls 
were analysed. The exons of the case and control were translated into amino acid sequence to 
identify if the changes at some positions lead to non-synonymous mutation. The translation was 
performed using an online tool: ExPasy (http://web.expasy.org/translate/). The translated 
sequences were then aligned using online tool: CLUSTALW 
(http://www.ebi.ac.uk/Tools/msa/clustalw2/). 
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RESULTS AND DISCUSSION 
The genome wide association study of a novel retinal disease that has been called pigmentary 
chorioretinopathy in Chinese crested dogs was mapped to a region on CFA 8. The two SNP’s with 
the strongest association were found in or in close proximity to the MDGA2 gene. This implies a 
possibility of identifying a causal mutation in the MDGA2 gene. All the results along with 
discussion are described below: 
Mode of inheritance:  
Initially, the pedigree was constructed to take account the relationship among the study samples 
that might lead to the population substructure which acts as one of the confounding factor in 
association studies. The Pedigrees of four families (Appendix section) were constructed by tracing 
back each individual to two or three generations toward the ancestor and also tracing forward the 
same individuals to its offspring. If individuals are traced further back then there is a chance of 
these families being related. 
The pedigree analysis of the Chinese crested case-control population implies autosomal recessive 
mode of inheritance as some of the key features observed in the pedigree are: presence of equal 
number of males and females affected in the population, the phenotype is skipping a generation 
for example if an individual “B1” in pedigree “B” is focussed, the disease is appearing in third 
generation where individual “B7” has a disease phenotype where as it’s parents are healthy and no 
disease is observed in that litter. Some matings that produce diseased offspring have at least one 
parent affected as can be observed in pedigree “A”, “A2” individual mated with a normal 
individual give many offspring with disease phenotype. Similarly, in pedigree B, B3 individual 
mated to normal give offspring B4 and B5 with disease phenotype.  
In pedigree D, the disease is occurring in each generation. Here, the D1 individual mated to 5 yrs 
old normal male give offspring D2 with disease phenotype. D2 when mated with a normal male (1 
year at age of examination) gives a diseased female diagnosed around 3 years of age. One half of 
each sex among offspring is affected. This family gives a picture as if disease is dominant and 
rare. However, many offspring with unknown phenotype are present in the pedigree. If they are 
normal then the chance of dominant mode of inheritance will decrease.  
 
The affected males mated with normal females transmit the disease to all the females but not 
males. This criterion for X-linked dominance is not fulfilled in the pedigree hence this mode of 
inheritance can be excluded. A2 male mated with normal female has female offspring in 2006 that 
is not affected by disease. Similarly, C2 in pedigree C mated to normal females give daughters 
with normal phenotype.  
 
The scenario of two affected parents is not observed in these pedigrees. In pedigree C, C1 female 
mated with a normal male give a normal male offspring. Similarly, in pedigree B, B1 affected 
female mated to an individual with unknown status give healthy male offspring in 2001 and 2002. 
This also helps to rule out the fact that the disease is X-linked recessive. Further, males and 
females are affected in almost equal numbers. 
 
From these conditions, the disease is segregating in a population at some point skipping 
generations. Hence, it can be concluded that the disease is genetic. Available pedigree information 
suggests that the disease is inherited according to a simple Mendelian autosomal recessive mode 
of inheritance. 
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Occurrences of eye disease in dogs have also been associated with mutations in mitochondrial 
DNA. There are some evidences that mutations in the mitochondrial genome would lead to 
functional defect in eyes. Leber’s hereditary optic neuropathy (LHON), retinitis pigmentosum 
(NARP-neuropathy, ataxia and retinitis pigmentosa) are some of the diseases that occur due to 
defect in function of the mitochondrial genome (Appleyard et al., 2006). In case of NARP there is 
a point mutation in MTATP6 gene that encodes for the subunit6 of F1FO-ATPase (Claude, 2012). 
However, the occurrence of such mitochondrial disease is transmitted from affected females to all 
the offspring. However, such scenario is not fulfilled in our pedigree and consequently this non 
Mendelian mode of inheritance could be ruled out. 
 
Many of the individual’s veterinary data are missing and hence their disease status is unknown. 
Only the diseased individuals have been traced to their offspring. The scenario might be different 
if we have more individuals with known disease status and also track down those healthy 
individuals in a litter that contains a diseased individual. This step might give a better picture and 
capture a wider population compared to the current situation. Also, to repeat the eye check of the 
normal individuals may also help, as many individuals are young when examined and the age of 
onset of disease varies a lot, starting early from ~3 years to ~10 years. 
 
The mode of inheritance generally helps to interpret the family history, potential risk of being 
susceptible to this disease and to make better use of the available genetic tests. The results from 
pedigree analysis can in this case be used to further develop the result obtained from GWA study. 
Such analysis provides an idea of what can be expected from the study being performed. The 
individual with diseased parents (recessive inheritance mode) is expected to have positive disease 
status. The result of GWAS for that individual is expected to have genotype of case.   However, 
lots of potential problems such as incomplete penetrance of disease, new mutations, pedigree 
errors, variable age of onset (as seen in our case), misclassifications etc. might reduce this benefit. 
But there can be situations, where pedigree information might help us to confirm occurrence of 
penetrance phenomenon. 
 
 
Genome Wide Association Study (GWAS): 
Multi Dimensional Scaling (MDS) plot: 
GWAS of 40 Chinese crested dogs (19 cases and 21 controls) was initially performed. To 
investigate the degree of stratification and relatedness among the sampled population an MDS 
plot was constructed using all 40 individuals. The classical multidimensional scaling, also referred 
to as Principal Coordinates Analysis, is primarily used to improve the visualisation of the 
relatedness among the individuals based on the genomic data. The relative distance among 
individuals in a distance matrix of 40 dimensions (axes) is converted to the points in certain 
desired number of scaling dimensions for simple interpretation. The Euclidean distance (straight 
line) between the scaling dimensions can give rise to the original distance matrix. The distance 
between the points representing individuals in the MDS plot is a straight line distance. MDS plots 
showing the genetic distance among the individuals in two dimensions can be observed in the 
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following figure 5a (left plot). In figures 5a, the cluster of four cases on the bottom right corner 
and three cases on the top left corner can be observed. 
 
  
Figure 7a  and 7b. MDS plot of 40 and 35 individuals (removing 5 cases) where each individual is 
represented by a circle, cases are coloured in red and controls in green. 
 
The individuals in the lower right corner of the plot were identified to be the full siblings. 
Similarly, two individuals out of three on the top leftmost corner of the plot were identified to be 
father and daughter. The relationship of third individual from Finland with other two couldn’t be 
identified due to missing veterinary data. In figures 5b Individuals seemed to be spread out 
without formation of any clusters. This indicates implying no indication of stratification. 
However, MDS plot can help us to observe any stratification to some extent only. 
 
Optimal number of cluster: 
Within group sum of squares (WSS) plotted against the number of clusters was used to group the 
study population into an adequate number of clusters. The location of a sharp bend in the plot can 
be used to estimate the optimal number of clusters (Kierczak et al., 2011). Through careful 
observation, a sharp bend can be seen on 4 no. of clusters in figure 6.  
 
Figure 8 Within cluster sum of squares obtained from each cluster is plotted against the number of 
clusters. 
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An optimum number of clusters to be considered is still not clear. In order to ensure optimum 
number of clusters to be used in association analysis through structured association approach the 
study sample was clustered into three different numbers of clusters: 3, 4 and 5. 
Clustering: 
Figure 9 below shows the individuals in the study samples clustered into different groups as we 
increase the number of clusters. In the plot, cluster 3, individuals divided into three clusters are 
represented by different colours as red, blue and green. These individuals are plotted on the basis 
of the pair wise identity by state (IBS) values. As, the cluster number is increased to 4, the 
individuals on the bottom part of the plot form a different cluster of green colour (figure: Cluster 
=4), inferring that they differ genetically from the rest of the members in the same cluster. 
Further, in figure cluster = 5, three individuals on the right of the plot forms a different cluster 
represented by black colour in the plot. This suggest that compared to three individuals who 
grouped into a different cluster (green cluster in figure: cluster =4) these three individuals in black 
clusters are genetically similar. This implies presence of stratification or relatedness in the study 
sample.  However, the members in other two clusters represented as blue and red in figure: cluster 
=3, doesn’t divide further into any groups.  
 
 
 
 
Figure 9 The population of 35 individuals divided into three, four and five subpopulations based 
on IBS-values. Each subpopulation is denoted by a specific colour in all three plots. 
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Association Analysis: 
Association analyses were performed with different models to ascertain that the associated SNP 
that we observe is not due to spurious association. The effect of variable “sex” was not significant 
to the disease phenotype status hence for approaches based on linear and mixed model, the fixed 
effects were only the genotype of individuals. The information of country of origin is also not 
taken into account because the practise of providing a registration number (identity number) to a 
dog is not very specific. In our sample, some Swedish dogs have parents from Finland and as the 
dog was brought here, Swedish registration number is provided. Due to such scenario, the 
information of country of origin may further mislead. 
Table 2 The table describes all the methods used for association analyses. The top three SNPs 
along with the chromosome number, position (base pair) of SNP in the chromosome, chi-square 
test statistic value, score provided to each SNP (P1df), corrected score (Pc1df) and Genomic 
inflation factor from each approach are given in the table. 
Methods:  SNP name Chr. Position chi-
square 
P1df Pc1df Inflation 
Basic 
 association 
BICF2P713861 8 26769490 21 4.59E-06 2.29E-05 1.170997 
TIGRP2P110467 8 27113849 19.53955 9.85E-06 4.41E-05 
BICF2S232422 5 32983613 18.95833 1.34E-05 5.73E-05 
        
Genomic 
 control 
 
 
 
TIGRP2P110467 8 27113849 22.75492 1.84E-06 6.19E-06 1.113844 
BICF2P713861 8 26769490 22.28774 2.35E-06 7.70E-06 
BICF2S232422 5 32983613 19.8935 8.19E-06 2.38E-05 
         
Structured  
association 
BICF2P713861 8 26769490 24.12909 9.01E-07 5.61E-06 1.170345 
 
3 clusters: 
TIGRP2P110467 8 27113849 24.11187 9.09E-07 5.65E-06 
BICF2P1044496 8 27972553 20.31726 6.56E-06 3.09E-05 
        
4 clusters: BICF2P713861 8 26769490 22.65861 1.93E-06 8.79E-06 1.146857 
TIGRP2P110467 8 27113849 22.63706 1.96E-06 8.88E-06 
TIGRP2P110728 8 27933541 19.42601 1.05E-05 3.86E-05 
        
 TIGRP2P110467 8 27113849 23.1011 1.54E-06 1.11E-05 1.196298 
5 clusters: BICF2P713861 8 26769490 22.93346 1.68E-06 1.20E-05 
TIGRP2P110728 8 27933541 19.26553 1.14E-05 5.99E-05 
        
Principal component                                
analysis: 
 
 
TIGRP2P110467 8 27113849 25.77222 3.84E-07 1.26E-05 1.351601 
BICF2P713861 8 26769490 25.50727 4.41E-07 1.40E-05 
BICF2S232422 5 32983613 22.69999 1.89E-06 4.16E-05 
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Different models have their own efficiency depending on the level of substructure in a population 
and relatedness among individuals (Aulchenko, 2010). Use of various models might also give an 
idea of the level of population stratification present and also the model that would better fit by 
correcting for the stratification. Table 2 gives an overview of the results obtained from all the 
models. The least value of λ 0.99 is observed with mixed model approach on 35 CCD and the 
maximum value of λ 1.35 is observed for PCA method. PCA is efficient method to be applied 
when the effect of substructure and relatedness among individuals is at medium level. But, as the 
value of inflation factor, λ >1, the study sample is affected of substructure or relatedness. The 
value of λ 1.14 is obtained when structured association method is applied for 35 individuals 
whereas the value of λ is 0.99 for mixed model. The value of λ > 1 in structured association gives 
a slight hint of high level of relatedness among individuals in the study sample which is taken into 
account by the mixed model approach. Similarly, value of λ is 1.02 when a combined approach of 
mixed model and structured association is applied on the population of 35 individuals by grouping 
population into four clusters. Both methods mentioned above seem to correct better for population 
structure and relatedness. Zhang et al. (2010) mentions that the statistical approach which leads to 
a distribution of observed negative logarithmic p-values close to the expected diagonal line 
corrects better for the false positive association. This concept could be applied to evaluate QQ plot 
from both above mentioned methods and to choose one method for further analysis. 
 
 
 
 
 
Mixed Model: 
 
 
TIGRP2P110467 8 27113849 21.50683 3.53E-06 3.51E-06 0.9996414 
BICF2P713861 8 26769490 21.39995 3.73E-06 3.71E-06 
BICF2S232422 5 32983613 19.05455 1.27E-05 1.27E-05 
       
        
Mixed model and  
Structure association: 
SNP name Chr. Position chi-
square 
P1df Pc1df Inflation 
 
3 clusters: 
 
 
 
BICF2P713861 8 26769490 22.24331 2.40E-06 3.09E-06 1.022345 
TIGRP2P110467 8 27113849 21.90407 2.87E-06 3.68E-06 
BICF2S232422 5 32983613 18.15447 2.04E-05 2.51E-05 
        
 
4 clusters: 
 
 
BICF2P713861 8 26769490 21.44949 3.63E-06 4.59E-06 1.021269 
TIGRP2P110467 8 27113849 20.97703 4.65E-06 5.84E-06 
BICF2P752103 8 26675235 18.34723 1.84E-05 2.25E-05 
        
5 clusters: BICF2P713861 8 26769490 20.7553 5.22E-06 7.00E-06 1.027856 
TIGRP2P110467 8 27113849 20.4185 6.22E-06 8.31E-06 
BICF2P752103 8 26675235 19.14179 1.21E-05 1.59E-05 
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Quantile Quantile (QQ) plot: 
 
Figure 10a QQ-plot for a combined approach (mixed model and structured association) 
 
Figure 10b QQ-plot for mixed model approach  
Figure 10a and 10b.Quantile-Quantile (QQ) plot of the distribution of negative logarithmic 
corrected p-values (black solid line) for the SNPs obtained from association analysis against the 
distribution of expected value (red diagonal line) under null hypothesis of no association. The 
grayish blue shade refers to the area bounded by confidence interval. The black solid line follows 
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diagonal red line to some extent and further along the tail, the values are deviating downward 
from the diagonal and only some markers deviate upward from the diagonal.  
 
The quantile quantile (QQ) plot is a standard tool  to diagnose  the population structure in GWAS 
(Pearson and Manolio, 2008) . The distribution of test statistics (p-values or chi-square) obtained 
from the association tests are compared with the distribution of expected test statistics under null 
hypothesis of no association. According to Pearson and Manolio (2008), the strong deviation from 
the null hypothesis of no association may occur due to presence of highly associated and heavily 
genotyped locus. It may also occur due to presence of high level of confounding factors 
(stratification, relatedness). Also, McCarthy et al. (2008) mentions that the deviation of p-values 
across the entire distribution is a result of population substructure or relatedness and the deviation 
at the significant end of the range is the one brought by the large-effect susceptibility loci.   
 
Here the QQ plot, figure 10a, of combined approach and of mixed model (figure 10b) appears to 
be very similar, but when observed carefully on negative logarithmic of p-value “4”, QQ plot of a 
combine approach seems to have values much closer to the diagonal line compared to mixed 
model approach. Hence a combined approach is selected and further analyses are performed.  
 
The scenario of the black solid line overlapping the red diagonal to some range fulfils pre-
assumption of GWAS that is many SNPs are not associated with disease phenotype. However, 
deviation of solid line downward the diagonal in both plots might be due to the effects of 
population structure and relatedness. The two points on top highly deviating from the diagonal 
suggest the association to disease phenotype. The points are still below the upper boundary of 
confidence interval which suggests that the association is not significant. 
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Manhattan plot: 
 
Figure 11Manhattan Plot for the association analysis using population of 35 individuals through 
a combined approach of Mixed model and Structured association taking into account four 
different clusters of the population 
In the figure 9, the negative logarithm of bonferroni corrected p-value (4.52e-07) =6.34 is 
represented by horizontal blue line. The horizontal orange line below is drawn for ease of 
visualization of top two SNPs on chromosome 8. The blue dots indicate raw p-value for the SNPs 
whereas the dots with brown and red border lines represent the corrected p-values for the same 
SNPs and are observed below the bonferroni corrected value. Also, the Pempirical values for the top 
two SNPs on chromosome 8 obtained after correction for multiple testing using Permutation 
method (10,000) times in GenABEL, can be viewed in blue colour (italic) next to the corrected 
values in the plot. The empirical p-value for the first SNP is 0.1201 > significance level (0.05). 
This infers that the association is not significant. Balding (2006) mentions that Bonferroni 
correction is regarded as overly conservative because the test of associations of markers with 
disease phenotype are considered as independent tests whereas in reality, due to linkage 
disequilibrium among markers different number of tests cannot be regarded as completely 
independent. This dependency of information is not taken into account in a testing procedure (p-
value based) of GWAS which results into the loss of efficiency (Wei et al., 2009). For further 
analysis, approaches such as Hidden Markov Model can be applied that takes into consideration 
the dependency information and improves the accuracy of multiple testing. Moreover, an addition 
of individuals for the association study will also lead to increment of the associated score. 
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Figure 12 Manhattan Plot of negative logarithmic p-values of the markers on zoomed region of 
chromosome 8 along with the minor allele frequency (MAF) of the markers on the lower part. The 
red line in the MAF region denotes 5% threshold of MAF for the markers. 
In the plot, the orange line is drawn in order to visualise the two SNPs easily. This plot suggests 
that the SNPs are not in the region of selective sweep. The region in a genome that displays 
reduced heterozygosity extended to certain region creating a long haplotype block fixed in a 
population describes selective sweep (Vaysse et al., 2011). It appears as a consequence of the 
selection of breed and genetic drift. In our scenario of case and control, the region of selective 
sweep denotes the region that is fixed for the whole population, hence no association will be seen 
in that region. The occurrence of the marker is highly unlikely in the region of selective sweep. As 
can be observed, both strongly associated markers are not present in the region of the selective 
sweep. 
 
 
 
Pairwise LD plot: 
Table 3 The top 10 SNPs in CFA 8 obtained on the basis of corrected p-value (Pc1df) are described in 
the table along with the position in chromosome. The markers are sorted on the basis of position left 
to right (increase in location number). The distance row gives distance between adjacent markers.  
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Figure 13 gives an image of how top 10 SNPs (mentioned in table 3) are located at CFA 8. Out of 
10 markers, 3 form one block which also contain one of the two strongly associated markers 
“TIGRP2P110467”. The total distance between the first and last SNP in the image is ~74, 000 bp. 
LD blocks can be observed as a black triangle that appears in the middle, but does not extend for 
too long due to recombination events that suggests to narrow down the region to the two strongly 
associated loci (from right to left, pointed by red arrows). The zoomed region for the two loci can 
be viewed in figure 14. 
 
 
Figure 13 Zoomed image of pair wise LD plot on the region of  chromosome 8 (from ~21298642 
 to ~27972553 )obtained from Haploview 4.2. The green line denotes the location of top 10 markers on 
chromosome 8 based on corrected p-values (scores) obtained from a combined approach of the mixed 
model and structured association. The designation of SNPs in the respective position next to the green 
line can be observed. For convenience the red arrows are used to point to the locations of some SNPs. 
Top two strongly associated are from the right pointed by red arrow below. 
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Figure 14  LD plot focussed to a region from ~“26675235” to  ~ “27972553” comprising around 300 Kb. 
The two strongly associated SNPs are visualised by a bounded by blue border line.  
In this clear picture of LD plot, pair wise LD values among markers are displayed on Confidence 
Bounds Color Scheme. Here, “Dark grey” refers to the evidence of strong LD (r2=1), “light grey” 
refers to uninformative LD (0 < r2 <1) and “white” refers to the strong evidence of recombination 
(r2 =0). The yellow circle on the dark grey area is the evidence of strong LD between the two 
strongly associated markers. 
Two strongly associated markers in figure 14 appear to be linked tightly with r2 =1. Only one of 
the two markers “TIGRP2P110467” is in a block of 25, 877 bp. The possible explanation might 
be that the threshold to exclude a marker on the basis of MAF is very low (1x10-03) such that a 
marker without enough heterozygosity is also included, hence it acts as uninformative giving 
value of pair wise LD not enough to define a block. However, the patterns of the block formation 
can be modified with the change in parameters (Barrett, 2009). For further analysis, each block 
considered as a haplotype can be used for association analysis. In GWAs the distribution and 
structure of haplotype blocks can help to identify complex disease genes (Wang et al., 2002). 
 
 
We can observe the genotypes of the individuals for the markers in figure 13 that might further 
help to explain the scenario in LD plot. The leftmost column contains “ID” of 35 individuals and 
the top part shaded with blue colour represents the control group and the lower part with pink 
shade represents the cases. The top two SNPs with strong association with disease phenotype is 
coloured in dark orange and third SNP in blue colour. The corrected p-values are mentioned as 
rows on top of the markers. The distance between these top two SNPs is 361,799 bp. Genotypes in 
the columns, “11” and “22” represents that individuals are homozygous for two different alleles 
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and is coloured in yellow and orange, respectively. Similarly, heterozygous genotype “12” is 
coloured in blue for ease of visualization. “NN” as seen in the white column denotes that the 
marker is not typed. The genotypes are extracted from the file without any prior quality control. 
 
 
Figure 15 The genotypes of individuals for SNPs on CFA 8 from position 26,675,235 to 27,158,294 
bp. 
 
The genotypes in the columns for two strongly associated SNPs infer a potential association with 
the disease, with the control mostly heterozygous and the cases mostly homozygous. The 
haplotype block with SNP “TIGRP2P110467” can be viewed from the right side, starting from 2nd 
to 4th SNP. An extended homozygosity block that can separate between cases and controls could 
not be determined. 
 
 Odds ratio: 
With the concept of LD, if the SNPs are in strong LD with the causative variant then odds ratio 
for the SNPs can also be related to the odds ratio of the causative variant. The Odds ratio (OR) of 
41.33 of the T-allele for SNP “BICF2P713861” with corrected P-value: 4.59E-06 indicates strong 
association of the allele with the disease phenotype as similar is the case with “G” allele of SNP 
“TICRP2P110467” (corrected p-value: 5.84E-06) with an OR of 37.52. The detailed result can be 
viewed in the table below: 
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Table 4 The OR for both alleles of two markers along with the confidence interval, p-value for test 
statistic, MAF distribution is described. For marker “BICF2P713861” G is the minor allele and has 
frequency of 0.35. For marker “TIGRP2P110467”, A is the minor allele with frequency of 0.338. p-
value <0.0001 denotes significance of test statistic.  
SNP  For 35 
indvs: 
      95% Conf. Interval     
  %Gen
o 
MA
F 
Allele
: 
Odds-
ratio 
Lower 
limit 
Upper 
limit 
Yates 
value 
p-
value 
BICF2P713861 
 
100 0.35 
(G) 
T 41.33 
 
5.1482 331.855 21.34 <0.000
1 
G 0.0242 0.003 0.1942 21.34 <0.000
1 
          95% Conf. Interval     
  %Geno MAF Allele
: 
Odds-ratio Lower limit Upper limit Yates 
value 
p-value 
TIGRP2P11046
7  
 
100 0.33
8 
(A) 
G 37.526 4.678 300.98 19.81 <0.000
1 
A 0.0266 0.0033 0.2137 19.81 <0.000
1 
 
Sequencing of the coding region: 
Analysis of the two markers ~300 kb apart in chromosome 8 revealed that SNPs lie in close 
proximity linked to a gene MDGA2/MAMDC1 (MAM-domain containing 
glycosylphosphatidylinositol anchor 2) in a genome browser Ensembl derived from CanFam 2.0 
assembly. According to Ensembl, MAMDC1 spans a region of 317.42 kb on reverse strand of 
CFA 8 (chromosome 14 in humans), consists of 15 exons and codes for a protein of 844 residues. 
There is >97% amino acid identity among mouse, rat, dog, chimpanzee, horse and human which 
implies an important function of this gene (Hellquist et al., 2009). This protein is predicted to be a 
new member of immunoglobulin superfamily (IgCAM) and plays role in cell adhesion, migration 
and recruitment to inflammatory sites. According to Genecards (www.genecards.org –version 
3.08), a database of human genes (known and predicted) the expression of MDGA2 is observed in 
retinal tissues of human. However, in Canine, the annotation of gene has been derived from 
human. According to UniProtKB (www.uniprot.org), version 10 (a resource for protein sequence 
and functional information), canine MDGA2 protein is not characterized. To date, MDGA2 
proteins have only been manually annotated for four species: human, rat, mouse and Cynomolgus 
monkey. 
 
Following results on table 5 were obtained for the sequencing of 1, 441 bp long promoter and 15 
exons for the cases and controls: 
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Table 5 The genotypes that differed for the cases and controls at different positions of promoter 
(denoted as Pro with numbers: 60, 234, 281, 895, 1023, 1138 and 1333) region, exon 6 (66th) and 
exon 15(228th) are described. “-“  represent identical nucleotide compared to the reference sequence 
at that position. 
 
 Positions 
 
Pro-
60 
Pro-
234 
Pro-
281 
Pro-
895 
Pro-
1023 
Pro-
1138 
Pro-
1333 
Exon 
6: 66 
Exon 
15: 
228 
Reference 
(Ensembl) 
A C T G A A Deletion T C 
 
 
CASES 
3 - - - - - - - - Y(C/T) 
15 R 
(G/A) 
Y 
(C/T) 
Y R R R W 
(A/T) 
W 
(A/T) 
M 
(A/C) 
33 R Y Y R R R W W Y 
36 R Y Y R R R T T C 
48 - - - - - - - - - 
 
 
CONTROLS 
8 G T C A G G T A T 
14 G Y C A R R T W M  
27 G T C A G G T W Y 
28 G T C A G G T W Y 
30 R Y Y R R R - W T 
 
There are seven positions in the promoter region where some cases and controls differed. Two of 
the cases (CCR 03 and CCR 48) are homozygous “A” for position 60 where as other cases are 
heterozygous “R: G/A”. All controls are homozygous “G” except for CCR30 which is 
heterozygous “R”. Similarly, genotypes of the cases and controls can be observed for other six 
positions mentioned in the region. At position 1333, all the controls have an insertion “T” except 
for CCR30. In cases, CCR15, CCR 33 and CCR36 have insertion. CCR 15 and CCR33 are 
heterozygous “W: A/T” whereas CCR36 is homozygous “T” for insertion. CCR03 and CCR 48 
don’t have any insertion in that position. 
For exon 6, cases CCR03, CCR 36 and CCR 48 are homozygous “T” for the position 66, where as 
other two cases CCR 15 and CCR 33 are heterozygous “W:A/T”. All the controls are 
heterozygous “W” except for CCR 08 which is homozygous “A”. For exon 15, two cases CCR 36 
and CCR 48 are homozygous “C” for position 228, CCR 15 is heterozygous “M:A/C” whereas 
CCR 03 and CCR 33 are heterozygous “Y: C/T”. In controls, CCR 08 and CCR 30 are 
homozygous “T”, CCR 27 and CCR 28 are heterozygous “Y: C/T” and CCR 14 is heterozygous 
“M: A/C”. 
With above analysis, only one case CCR 48 and CCR 08 are homozygous in every position and 
differ from one another. Also, CCR 48 is identical to the reference sequence where as CCR08 is 
not. This result is not conclusive and a definite conclusion can be derived with addition of more 
individuals in the sequence analysis.  
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The multiple alignment of translated sequence (844 residues) for one case (CCR48) and one 
control (CCR08) along with the reference amino acid residue from Ensembl determined a non-
synonymous change on position 348 where the essential amino acid “T”-Threonine on reference 
sequence is changed to non-essential amino acid “S”-Serine in the control sample. Both amino 
acids are polar (hydrophilic) in nature. Multiple aligned sequences can be observed in the 
appendix section. 
The changes in different nucleotides for the cases and controls need to be justified as the reference 
sequence used is based on predicted annotation. New canine assembly CanFam 3.1 has been 
developed (personal information). The predicted annotation for MDGA2 gene can be evaluated 
for any incomplete explanation of the region. If new features are available for example change in 
exon annotation then, Exome sequencing can be performed for those exons. Other possible steps 
can be sequencing of a whole region of MDGA2, around 300 kb in length, to identify causal 
variant for disease phenotype. Another approach could be to isolate mRNA from the retinal tissue 
and compare the expression profile of the specific gene in the tissue (Shimizu-Matsumoto et al., 
1997). Mutations are not always non-synonymous. Hence, an approach that has a capacity to 
detect as many potential ways of causing mutations should be applied for mutational screening. 
 
In GWAS the association observed could be direct, indirect or spurious. The association is direct 
when the associated marker is itself involved in causing a disease. An indirect association occurs 
when the associated allele is not directly involved but is in LD with the alleles causing disease. 
The occurrence of two SNPs on CFA 8 in almost all models with least value for the chance of 
false positive error strengthens a possibility of obtained SNPs to be truly associated with disease 
phenotype and not a spurious association although this association is not significant after 
correcting for the multiple testing using Bonferroni correction and Permutation methods. 
However, the potential association to chromosome 8 can be further evaluated. GWAS is 
susceptible to many errors and biases. The spurious association might be related to statistical 
fluctuations (occur by chance and generate low p-values), bias due to study design and due to 
some technical errors (Hirschhorn and Daly, 2005). Hence to evaluate the association from GWA 
finding, replication plays a crucial role (McCarthy et al., 2008). Replication helps to identify the 
associations that are reproducible by evaluating the associations in other independent samples 
hence validating a true association. To avoid spurious association one of the essential criteria is to 
have a distinct definition for a disease that we are analysing. However, in this case, age of onset 
among cases vary from ~3 yrs to ~11 yrs. Again, epistasis, interaction of gene and environment 
influences such factors and complicates a specific definition for a disease.  
 
Karlsson et al. (20007) mentions that due to a genome structure of dogs and variation within and 
across different breeds of dogs, the region associated with certain trait could be identified initially 
within a breed using a sparse marker set (presence of long haplotype blocks due to extended LD) 
and further, the region could be confirmed by using a dense marker array taking multiple breeds 
(short haplotype blocks across breeds). For e.g:  Mapping a coat colour locus in white boxer and 
bull terrier initially by independent association analysis within both breeds and further association 
analysis including both breeds to fine map the region of association. This application of this 
approach seems to be a bit complicated in case of CCD. Firstly, the disease is rare in a population 
of CCD that collection of unrelated samples to avoid stratification is quite complicated. Such 
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features of a disease have not been reported in any other breeds apart from CCD. Hence, 
performing a GWAS across breeds seems to be complicated in case of CCD. 
 
After revision of all the results, the two SNPs on CFA 8 identified with strong association to the 
disease phenotype can be taken as the potential SNPs. Further work related with this study can be 
directed in many ways. In order to confirm it as a significant association, association analysis with 
additional dogs need to be performed. As the SNPs appear to be potential marker, a gene MDGA2 
linked to their loci also seems as a potential candidate gene, however further analysis need to be 
done for a definite conclusion. Also, MDGA2 molecule is highly expressed in peripheral and 
central nervous system and is involved in cell adhesion (Joset et al., 2011). A primary feature of 
this retinal disease includes detachment of RPE cells and migration toward the outer segment of 
photoreceptor cells and retina is a part of the central nervous system with different neuronal layers 
involved in transferring stimuli from photoreceptor cells to the optic nerve. These scenarios also 
suggest MDGA2 to be a potential candidate for the disease. Hence, MDGA2 gene should be 
further evaluated based on the annotation obtained from a new CanFam 3.1 assembly (which is 
currently unavailable). Hence, an identification of the genetic basis of any disease helps in 
developing the molecular tools to better diagnose the disease and better application in field of 
breeding to create healthy population. 
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APPENDIX 
 
Commands:  
These are the commands used in GenABEL package in R.  
 
#### To convert plink files to GenABEL format: 
convert.snp.ped("data.ped", "data_edited.map", "genotype.raw") 
 
### Loading files: 
load.gwaa.data(pheno="phenotype.dat", geno="genotype.raw", makemap=FALSE, sort=TRUE) -
> data 
 
##### First quality control: 
check.marker(data, call=0.95, perid.call=0.95,extr.call=0.1, 
extr.perid.call=0.1,ibs.threshold=0.95,ibs.mrk="all",ibs.exclude="both",maf=1e-08, p.lev=1e-08, 
XXY.call=0.8, intermediateXF=c(0.5, 0.5)) -> firstqc 
 
##### Transferring edited data to new data1: 
data1 <- data[firstqc$idok, firstqc$snpok] 
 
####### To check association of “sex” variable to the disease status: 
tab <- table(phdata(data1)$status, phdata(data1)$sex) 
fisher.test(tab) 
 
##### Making genomic kinship matrix: 
autosomalmarkers <- which(chromosome(data1) != "39") 
length(autosomalmarkers) 
autosomalmarkernames <- snpnames(data1)[autosomalmarkers] 
data1genomickinship <- ibs(data1 [ , autosomalmarkernames], weight ="freq") 
data1distance <- as.dist(0.5 - data1genomickinship) 
 
##### To make classical MDS plot and K=5 denotes the number of principal components shown: 
data1mds <- cmdscale(data1distance, k=5) 
 
###### Assigning case and control group to datamds: 
controls <- which(phdata(data1)$status == 0) 
controlsX <- data1mds [controls, 1] 
controlsY <- data1mds [controls, 2] 
cases <- which(phdata(data1)$status == 1) 
39 
 
casesX <- data1mds[cases, 1] 
casesY <- data1mds[cases, 2] 
 
###### Making MDS plot coloring Cases and Controls: 
plot(data1mds, xlab="MDS1", ylab="MDS2") 
points(controlsX, controlsY, pch=19, cex=0.7, col="green") 
points(casesX, casesY, pch=19, cex=0.7, col="red") 
legend(x="topright", c("cases", "controls"), col=c("red", "green"), pch=c(19, 19), ncol=1, 
bty="n", pt.cex= c(0.5, 0.5)) 
 
 
###### Identifying outliers and removing them (this process is done only while removing 
outliers): 
#####outliers <- identify(data1mds) 
####outliers 
 
##### outliers and non_outliers names: 
###outliers_names <- phdata(data1)[outliers,]$id 
###non_outliers_names <- phdata(data1)[-outliers,]$id 
###outliers_names 
 
#### Transferring non outlier to data2: 
###data2 <- data1[non_outliers_names,] 
###nids(data2) 
 
##### Second quality control without removing outliers: 
check.marker(data1, hweids=(phdata(data1)$status == 0), call=0.95, perid.call=0.95, maf=0.05, 
fdrate=0.2) -> secondqc 
data2 <- data1[secondqc$idok, secondqc$snpok] 
nsnps(data2) 
 
###### Fast case-control analysis computes chi-square test from 2x2 (allelic) or 2x3 (genotypic) 
tables: 
ANfast_cc <- ccfast("status", data2, clambda=FALSE,propPs=1.0) 
lambda(ANfast_cc) 
descriptives.scan(ANfast_cc, top=30, sort="Pc1df") 
 
bonferroni <- -log10(0.05/nsnps(data2)) 
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###### Genomic Control: 
ANgc <- qtscore(status, data2, trait.type="binomial", clambda=FALSE, propPs) 
 
##### Firstly make genomic kinship matrix from data2 which passed second quality control test 
and then make second MDS plot from the new data and do Classical multidimensional scaling...  
data2distance <- as.dist(0.5 - data2genomickinship) 
data2mds <- cmdscale(data2distance) 
 
 
#### To determine the structure in the population: 
wss <- (nrow(data2mds) - 1) * sum(apply(data2mds, 2, var)) 
for (i in 2:10) wss[i] <- sum(kmeans(data2mds,centers=i, nstart=nids(data2))$withinss) 
plot(1:10, wss, type="b", xlab="Number of Clusters", ylab="WSS") 
 
#### Making three clusters: 
km <- kmeans(data2mds, centers=3, nstart=nids(data2)) 
 
#### Determine clusters and coordinates of individuals for one cluster, similar procedure can be 
performed for other clusters: 
 
cl1 <- which(km$cluster == 1) 
cl1num <- as.numeric(cl1) 
cl1x <- data2mds[cl1num,1] 
cl1y <- data2mds[cl1num,2] 
 
plot(data2mds,type="n", xlab="MDS1",ylab="MDS2", main="Subpopulations (K=3)") 
points(cl1x, cl1y, pch=19, cex=.5, col="red") 
legend(x="topright", c("subpop 1", "subpop 2", "subpop 3"),col=c("red","blue","yellow"), 
pch=c(19,19,19), ncol=1, bty="n", pt.cex=c(0.5,0.5,0.5)) 
 
####### To find the individuals that are in each specific clusters: 
cl1names <- names(which(km$cluster == 1)) 
cl1names 
 
###### Taking strata into account: 
 
##### When strata is taken into account then scores are computed within strata and then added 
up: 
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ANgc_sa <- qtscore(status, data2, strata= cluster_3, trait.type="binomial", clambda=FALSE, 
propPs) 
 
##### make a polygenic model for Mixed model: 
h2a <- polygenic_hglm(status, data2, kin=data2genomickinship, trait="binomial") 
 
##### Mixed model approach without permutation: 
ANmixedmodel <- mmscore(h2a, data2) 
 
###Mixed model approach and Structured association without permutation: 
ANmmsa <- mmscore(h2a, data2, strata=cluster_3) 
 
 
####Mixed model approach with 10000 permutations: 
ANmixedmodel_perm <- mmscore(h2a, data2, times=10000) 
 
###### Eigenscore (PCA): 
#### Firstly, the diagonal of the genomic kinship matrix is replaced by the variance using hom() 
function: 
diag(data2genomickinship) <- hom(data2[ , autosomalmarkers])$Var 
ANeigen <- egscore(status, data2, kinship=data2genomickinship) 
 
The commands for QQ plot and Manhattan plot are not mentioned here. 
 
Primers: 
20 different M13 tailed primer pairs used for Exome sequencing of MDGA2 gene: 
Oligoname M13 tailed primer Tm Product 
size 
MDGA2_Pro1_Frw TGTAAAACGACGGCCAGTtgctggtatccctaagttcactg 60.54 565 
MDGA2_Pro1_Rev CAGGAAACAGCTATGACCtccaccaattcataatgcactc 59.83 
MDGA2_Pro2_Frw TGTAAAACGACGGCCAGTtgggaaaatttgggattctg 59.73 659 
MDGA2_Pro2_Rev CAGGAAACAGCTATGACCaacaagctcttggttccatgt 58.71 
MDGA2_Pro3_Frw TGTAAAACGACGGCCAGTtgatgaggaagtctaagagcaca 59.14 583 
MDGA2_Pro3_Rev CAGGAAACAGCTATGACCgttgcggagtcccagtaaaa 60.11 
MDGA2_Pro4_Frw TGTAAAACGACGGCCAGTttgcaaaatgatcaccacaa 58.52 621 
MDGA2_Pro4_Rev CAGGAAACAGCTATGACCcactgggttaagtttttccttca 59.56 
MDGA2_E1_Frw TGTAAAACGACGGCCAGTcaagttcatacaaagcccaaga 59.27 402 
MDGA2_E1_Rev CAGGAAACAGCTATGACCagccgaaacaatgaaacaca 59.17 
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MDGA2_E2_Frw TGTAAAACGACGGCCAGTtgaaaatgcacctttggtca 60.09 410 
MDGA2_E2_Rev CAGGAAACAGCTATGACCtcaaaggtcagatttggaaaga 58.81 
MDGA2_E3_Frw TGTAAAACGACGGCCAGTaagacagtctgccacattttga 59.78 364 
MDGA2_E3_Rev CAGGAAACAGCTATGACCggggagcagagatgacttgt 59.26 
MDGA2_E4_Frw TGTAAAACGACGGCCAGTtgattttggcaaaggaaaaga 59.68 500 
MDGA2_E4_Rev CAGGAAACAGCTATGACCtgcatgcaatatttgaggaaa 59.16 
MDGA2_E5_Frw TGTAAAACGACGGCCAGTcatgttagcacagcacttgga 59.92 634 
MDGA2_E5_Rev CAGGAAACAGCTATGACCtttatcgggcaatcagaacg 60.96 
MDGA2_E6_Frw TGTAAAACGACGGCCAGTcaaccagcagaaattgtttcc 59.6 490 
MDGA2_E6_Rev CAGGAAACAGCTATGACCccctaacccaatcacaaaatc 58.29 
MDGA2_E7_Frw TGTAAAACGACGGCCAGTcggctattgttctccaacca 61.02 500 
MDGA2_E7_Rev CAGGAAACAGCTATGACCgacaagctactcaaagtatgttcca 58.94 
MDGA2_E8_Frw TGTAAAACGACGGCCAGTtcgtctcttcctctcgcact 60.28 472 
MDGA2_E8_Rev CAGGAAACAGCTATGACCcctgggatttatgcaaaatgat 60.04 
MDGA2_E9_Frw TGTAAAACGACGGCCAGTtttttgcccattttgttagaa 57.39 395 
MDGA2_E9_Rev CAGGAAACAGCTATGACCttggctgatgatccagaaga 59.32 
MDGA2_E10_Frw TGTAAAACGACGGCCAGTatggtcacagtggggaagat 59.23 329 
MDGA2_E10_Rev CAGGAAACAGCTATGACCtgtctttgtacccatactcatcaaa 59.82 
MDGA2_E11_Frw TGTAAAACGACGGCCAGTggcgccactattccaatct 60.05 384 
MDGA2_E11_Rev CAGGAAACAGCTATGACCagcattctgttgcatgtcatatt 58.67 
MDGA2_E12_Frw TGTAAAACGACGGCCAGTtttcaatgagatcaaaattctcc 57.37 377 
MDGA2_E12_Rev CAGGAAACAGCTATGACCtcgacttcatgctcatgtttg 59.86 
MDGA2_E13_Frw TGTAAAACGACGGCCAGTaacaccacagattcaagggatt 71.5 - 
MDGA2_E13_Rev CAGGAAACAGCTATGACCgagaattgactatccagcttcca 72.4 
MDGA2_E14_Frw TGTAAAACGACGGCCAGTggtttggcttttcaatttctca 60.45 427 
MDGA2_E14_Rev CAGGAAACAGCTATGACCtgcttgccttacacagacca 60.45 
MDGA2_E15_e1Frw TGTAAAACGACGGCCAGTtttccttttcacatgtcttgga 59.59 644 
MDGA2_E15_e1Rev CAGGAAACAGCTATGACCtgaaacaaaaccagccatga 60.09 
MDGA2_E15_e2Frw TGTAAAACGACGGCCAGTaggcactggcatgaagaaag 60.4 426 
MDGA2_E15_e2Rev CAGGAAACAGCTATGACCatgccagctcttcacgtacc 60.29 
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Top 10 SNPs for different models of association analysis for 35 individuals: 
Basic Association analysis: 
  Chromosome Position chi2.1df P1df Pc1df 
BICF2P713861 8 26769490 21 4.59E-06 2.29E-05 
TIGRP2P110467 8 27113849 19.53955 9.85E-06 4.41E-05 
BICF2S232422 5 32983613 18.95833 1.34E-05 5.73E-05 
BICF2G63035030 5 32197936 17.84257 2.40E-05 9.48E-05 
BICF2G630555875 7 33168942 17.32323 3.15E-05 1.20E-04 
BICF2P1341155 7 38798709 17.32323 3.15E-05 1.20E-04 
BICF2P1195666 7 38810664 17.32323 3.15E-05 1.20E-04 
BICF2G630558054 7 38778586 16.48263 4.91E-05 1.76E-04 
BICF2P619504 19 38930835 16.48263 4.91E-05 1.76E-04 
BICF2G630339850 3 43489192 16.12802 5.92E-05 2.06E-04 
BICF2P739313 5 34211721 15.2381 9.48E-05 3.09E-04 
      
      Inflation factor 1.170997 
     
   
  
Genomic control: 
  Chromosome Position chi2.1df P1df Pc1df 
TIGRP2P110467 8 27113849 22.75492 1.84E-06 6.19E-06 
BICF2P713861 8 26769490 22.28774 2.35E-06 7.70E-06 
BICF2S232422 5 32983613 19.8935 8.19E-06 2.38E-05 
BICF2P1044496 8 27972553 18.32265 1.86E-05 5.00E-05 
BICF2P752103 8 26675235 16.07506 6.09E-05 1.45E-04 
TIGRP2P110728 8 27933541 15.72401 7.33E-05 1.72E-04 
BICF2P1229493 8 28034747 15.72401 7.33E-05 1.72E-04 
TIGRP2P110779 8 28046595 15.72401 7.33E-05 1.72E-04 
BICF2P1271232 8 28382745 15.72401 7.33E-05 1.72E-04 
BICF2S2308001 12 48682591 14.58333 1.34E-04 2.96E-04 
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Inflation factor           
1.113844           
 
  
 
Structured Association: 
For strata =3 
 
 3 clusters: Chromosome Position chi2.1df P1df Pc1df 
BICF2P713861 8 26769490 24.12909 9.01E-07 5.61E-06 
TIGRP2P110467 8 27113849 24.11187 9.09E-07 5.65E-06 
BICF2P1044496 8 27972553 20.31726 6.56E-06 3.09E-05 
BICF2S232422 5 32983613 19.61502 9.47E-06 4.24E-05 
BICF2P752103 8 26675235 19.23058 1.16E-05 5.04E-05 
BICF2S22946314 8 27895878 16.79685 4.16E-05 1.52E-04 
TIGRP2P110728 8 27933541 16.5007 4.86E-05 1.73E-04 
BICF2P1229493 8 28034747 16.5007 4.86E-05 1.73E-04 
TIGRP2P110779 8 28046595 16.5007 4.86E-05 1.73E-04 
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BICF2P1271232 8 28382745 16.5007 4.86E-05 1.73E-04 
            
            
 Inflation factor 1.170345         
 
 For 4 clusters: Chromosome Position chi2.1df P1df Pc1df 
BICF2P713861 8 26769490 22.65861 1.93E-06 8.79E-06 
TIGRP2P110467 8 27113849 22.63706 1.96E-06 8.88E-06 
TIGRP2P110728 8 27933541 19.42601 1.05E-05 3.86E-05 
BICF2P1044496 8 27972553 19.42601 1.05E-05 3.86E-05 
BICF2P1229493 8 28034747 19.42601 1.05E-05 3.86E-05 
TIGRP2P110779 8 28046595 19.42601 1.05E-05 3.86E-05 
BICF2P1271232 8 28382745 19.42601 1.05E-05 3.86E-05 
BICF2P752103 8 26675235 18.13413 2.06E-05 7.00E-05 
TIGRP2P109371 8 23439519 17.71218 2.57E-05 8.50E-05 
BICF2S232422 5 32983613 17.44376 2.96E-05 9.62E-05 
            
Inflation: 1.146857         
 
 
 For 5 clusters: Chromosome Position chi2.1df P1df Pc1df 
TIGRP2P110467 8 27113849 23.1011 1.54E-06 1.11E-05 
BICF2P713861 8 26769490 22.93346 1.68E-06 1.20E-05 
TIGRP2P110728 8 27933541 19.26553 1.14E-05 5.99E-05 
BICF2P1044496 8 27972553 19.26553 1.14E-05 5.99E-05 
BICF2P1229493 8 28034747 19.26553 1.14E-05 5.99E-05 
TIGRP2P110779 8 28046595 19.26553 1.14E-05 5.99E-05 
BICF2P1271232 8 28382745 19.26553 1.14E-05 5.99E-05 
BICF2P752103 8 26675235 19.21474 1.17E-05 6.13E-05 
TIGRP2P109371 8 23439519 19.02244 1.29E-05 6.67E-05 
BICF2S23649439 8 21298642 18 2.21E-05 1.05E-04 
            
Inflation: 1.196298         
Principal component analysis: 
  Chromosome Position chi2.1df P1df Pc1df 
TIGRP2P110467 8 27113849 25.77222 3.84E-07 1.26E-05 
BICF2P713861 8 26769490 25.50727 4.41E-07 1.40E-05 
BICF2S232422 5 32983613 22.69999 1.89E-06 4.16E-05 
BICF2P1044496 8 27972553 20.83687 5.00E-06 8.62E-05 
BICF2P752103 8 26675235 19.94519 7.97E-06 1.22E-04 
TIGRP2P109371 8 23439519 19.8398 8.42E-06 1.27E-04 
BICF2G630194324 26 39882788 18.46203 1.73E-05 2.19E-04 
BICF2P144600 29 15437619 18.17722 2.01E-05 2.45E-04 
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 BICF2G63035789 5 32972070 17.99923 2.21E-05 2.63E-04 
BICF2S23649439 8 21298642 17.96072 2.26E-05 2.67E-04 
BICF2P692633 5 34675781 17.5517 2.80E-05 3.14E-04 
            
 inflation 1.351601         
 
 
Mixed model: 
  Chromosome Position chi2.1df P1df Pc1df 
TIGRP2P110467 8 27113849 21.50683 3.53E-06 3.51E-06 
BICF2P713861 8 26769490 21.39995 3.73E-06 3.71E-06 
BICF2S232422 5 32983613 19.05455 1.27E-05 1.27E-05 
BICF2P752103 8 26675235 16.70483 4.37E-05 4.35E-05 
BICF2P1044496 8 27972553 15.17054 9.82E-05 9.79E-05 
BICF2G63035030 5 32197936 14.62165 1.31E-04 1.31E-04 
BICF2G630558054 7 38778586 13.99363 1.83E-04 1.83E-04 
BICF2S2308001 12 48682591 13.67068 2.18E-04 2.17E-04 
BICF2G63031325 5 28659812 13.62211 2.24E-04 2.23E-04 
TIGRP2P109371 8 23439519 13.39441 2.52E-04 2.52E-04 
            
 Inflation:   0.9996414       
 
Mixed model and structured association: 
 For 3 clusters: Chromosome Position chi2.1df P1df Pc1df 
BICF2P713861 8 26769490 22.24331 2.40E-06 3.09E-06 
TIGRP2P110467 8 27113849 21.90407 2.87E-06 3.68E-06 
BICF2S232422 5 32983613 18.15447 2.04E-05 2.51E-05 
BICF2P752103 8 26675235 18.03192 2.17E-05 2.67E-05 
BICF2P1044496 8 27972553 15.94452 6.52E-05 7.84E-05 
BICF2G63031325 5 28659812 14.41084 1.47E-04 1.74E-04 
BICF2G63035030 5 32197936 13.75645 2.08E-04 2.44E-04 
BICF2S2308001 12 48682591 13.27211 2.69E-04 3.14E-04 
TIGRP2P110728 8 27933541 13.21058 2.78E-04 3.25E-04 
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BICF2P1229493 8 28034747 13.21058 2.78E-04 3.25E-04 
      TIGRP2P110779 8 28046595 13.21058 2.78E-04 3.25E-04 
            
 Inflation: 1.022345         
 
 For 5 clusters: Chromosome Position chi2.1df P1df Pc1df 
BICF2P713861 8 26769490 20.7553 5.22E-06 7.00E-06 
TIGRP2P110467 8 27113849 20.4185 6.22E-06 8.31E-06 
BICF2P752103 8 26675235 19.14179 1.21E-05 1.59E-05 
BICF2S232422 5 32983613 16.86516 4.01E-05 5.11E-05 
BICF2G630194640 26 39699790 16.28962 5.44E-05 6.86E-05 
BICF2P638018 8 23630740 16.06417 6.12E-05 7.71E-05 
BICF2P1065138 8 23650115 16.06417 6.12E-05 7.71E-05 
TIGRP2P109371 8 23439519 15.64517 7.64E-05 9.56E-05 
BICF2P1391407 8 22082613 15.22084 9.56E-05 1.19E-04 
BICF2S23649439 8 21298642 14.66008 1.29E-04 1.59E-04 
BICF2P1044496 8 27972553 14.55826 1.36E-04 1.68E-04 
            
 inflation 1.027856         
 
 
Multiple Alignment Sequence: 
Yellow coloured area is the one where difference can be seen between case (CCR48) and control 
(CCR08). 
 
CLUSTAL 2.1 multiple sequence alignment 
 
 
dog_ensembl       LTQPFISTFQISKYNLLDDPVVTVHQSIGEAKEQFYYERTVFLRCVANSNPPVRYSWRRG 60 
CCR48_frame1      LTQPFISTFQISKYNLLDDPVVTVHQSIGEAKEQFYYERTVFLRCVANSNPPVRYSWRRG 60 
CCR08_frame1      LTQPFISTFQISKYNLLDDPVVTVHQSIGEAKEQFYYERTVFLRCVANSNPPVRYSWRRG 60 
                  ************************************************************ 
 
dog_ensembl       QEVLLQGSDKGVEIYEPFFTQGETKILKLKNLRPQDYANYSCIASVRNVCNIPDKMVSFR 120 
CCR48_frame1      QEVLLQGSDKGVEIYEPFFTQGETKILKLKNLRPQDYANYSCIASVRNVCNIPDKMVSFR 120 
CCR08_frame1      QEVLLQGSDKGVEIYEPFFTQGETKILKLKNLRPQDYANYSCIASVRNVCNIPDKMVSFR 120 
                  ************************************************************ 
 
dog_ensembl       LSNKTASPSIKLLVDDPIVVNPGEAITLVCVTTGGEPAPTLTWVRSFGTLPEKTVLNGGT 180 
CCR48_frame1      LSNKTASPSIKLLVDDPIVVNPGEAITLVCVTTGGEPAPTLTWVRSFGTLPEKTVLNGGT 180 
CCR08_frame1      LSNKTASPSIKLLVDDPIVVNPGEAITLVCVTTGGEPAPTLTWVRSFGTLPEKTVLNGGT 180 
                  ************************************************************ 
 
dog_ensembl       LTIPAITSEDAGTYSCIANNNVGNPAKKSTNIIVRALKKGRFWITPDPYHKDDNIQIGRE 240 
CCR48_frame1      LTIPAITSEDAGTYSCIANNNVGNPAKKSTNIIVRALKKGRFWITPDPYHKDDNIQIGRE 240 
CCR08_frame1      LTIPAITSEDAGTYSCIANNNVGNPAKKSTNIIVRALKKGRFWITPDPYHKDDNIQIGRE 240 
                  ************************************************************ 
 
dog_ensembl       VKISCQVEAVPSEELTFSWFKNGRPLRSSERMVITQTDPDVSPGTTNLDIIDLKFTDFGT 300 
CCR48_frame1      VKISCQVEAVPSEELTFSWFKNGRPLRSSERMVITQTDPDVSPGTTNLDIIDLKFTDFGT 300 
CCR08_frame1      VKISCQVEAVPSEELTFSWFKNGRPLRSSERMVITQTDPDVSPGTTNLDIIDLKFTDFGT 300 
                  ************************************************************ 
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dog_ensembl       YTCVASLKGGGISDISIDVNISSSTVQVPPNLTVPQEKSPLVTREGDTIELQCQVTGKPK 360 
CCR48_frame1      YTCVASLKGGGISDISIDVNISSSTVQVPPNLTVPQEKSPLVTREGDTIELQCQVTGKPK 360 
CCR08_frame1      YTCVASLKGGGISDISIDVNISSSTVQVPPNLTVPQEKSPLVTREGDSIELQCQVTGKPK 360 
                  ***********************************************:************ 
 
dog_ensembl       PIILWSRADKEVAMPDGSMQMESYDGTLRIVNVSREMSGMYRCQTSQYNGFNVKPREALV 420 
CCR48_frame1      PIILWSRADKEVAMPDGSMQMESYDGTLRIVNVSREMSGMYRCQTSQYNGFNVKPREALV 420 
CCR08_frame1      PIILWSRADKEVAMPDGSMQMESYDGTLRIVNVSREMSGMYRCQTSQYNGFNVKPREALV 420 
                  ************************************************************ 
 
dog_ensembl       QLIVQYPPAVEPAFLEIRQGQDRSVTMSCRVLRAYPIRVLTYEWRLGNKLLRTGQFDSQE 480 
CCR48_frame1      QLIVQYPPAVEPAFLEIRQGQDRSVTMSCRVLRAYPIRVLTYEWRLGNKLLRTGQFDSQE 480 
CCR08_frame1      QLIVQYPPAVEPAFLEIRQGQDRSVTMSCRVLRAYPIRVLTYEWRLGNKLLRTGQFDSQE 480 
                  ************************************************************ 
 
dog_ensembl       YTEYPVKSLSNENYGVYNCSIINEAGAGRCSFLVTGKAYAPEFYYDTYNPVWQNRHRVYS 540 
CCR48_frame1      YTEYPVKSLSNENYGVYNCSIINEAGAGRCSFLVTGKAYAPEFYYDTYNPVWQNRHRVYS 540 
CCR08_frame1      YTEYPVKSLSNENYGVYNCSIINEAGAGRCSFLVTGKAYAPEFYYDTYNPVWQNRHRVYS 540 
                  ************************************************************ 
 
dog_ensembl       YSLQWTQMNPDAVDRIVAYRLGIRQAGQQRWWEQEIKINGNIQKGELITYNLTELIKPEA 600 
CCR48_frame1      YSLQWTQMNPDAVDRIVAYRLGIRQAGQQRWWEQEIKINGNIQKGELITYNLTELIKPEA 600 
CCR08_frame1      YSLQWTQMNPDAVDRIVAYRLGIRQAGQQRWWEQEIKINGNIQKGELITYNLTELIKPEA 600 
                  ************************************************************ 
 
dog_ensembl       YEVRLTPLTKFGEGDSTIRVIKYSAPVNPHLREFHCGFEDGNICLFTQDDTDNFDWTKQS 660 
CCR48_frame1      YEVRLTPLTKFGEGDSTIRVIKYSAPVNPHLREFHCGFEDGNICLFTQDDTDNFDWTKQS 660 
CCR08_frame1      YEVRLTPLTKFGEGDSTIRVIKYSAPVNPHLREFHCGFEDGNICLFTQDDTDNFDWTKQS 660 
                  ************************************************************ 
 
dog_ensembl       TATRNTKYTPNTGPNADRSGSKEGFYMYIETSRPRLEGEKARLLSPVFSIAPKNPYGPTN 720 
CCR48_frame1      TATRNTKYTPNTGPNADRSGSKEGFYMYIETSRPRLEGEKARLLSPVFSIAPKNPYGPTN 720 
CCR08_frame1      TATRNTKYTPNTGPNADRSGSKEGFYMYIETSRPRLEGEKARLLSPVFSIAPKNPYGPTN 720 
                  ************************************************************ 
 
dog_ensembl       TAYCFSFFYHMYGQHIGVLNVYLRLKGQTTIENPLWSSSGNKGQRWNEAHVNIYPITSFQ 780 
CCR48_frame1      TAYCFSFFYHMYGQHIGVLNVYLRLKGQTTIENPLWSSSGNKGQRWNEAHVNIYPITSFQ 780 
CCR08_frame1      TAYCFSFFYHMYGQHIGVLNVYLRLKGQTTIENPLWSSSGNKGQRWNEAHVNIYPITSFQ 780 
                  ************************************************************ 
 
dog_ensembl       LIFEGIRGPGIEGDIAIDDVSIAEGECAKQDLTTKNSVDGAVGILVHLWLFPVIVLISIL 840 
CCR48_frame1      LIFEGIRGPGIEGDIAIDDVSIAEGECAKQDLTTKNSVDGAVGILVHLWLFPVIVLISIL 840 
CCR08_frame1      LIFEGIRGPGIEGDIAIDDVSIAEGECAKQDLTTKNSVDGAVGILVHLWLFPVIVLISIL 840 
                  ************************************************************ 
 
dog_ensembl       SPRR- 844 
CCR48_frame1      SPRR- 844 
CCR08_frame1      SPRR- 844 
                  ****                                                         
 
                                                      
 
Chromatogram of Sequence Analysis of MDGA2: 
The difference in nucleotide between a case and a control can be observed in the chromatogram 
analysed through Codon code aligner (4.0.2). The vertical blue line is passed along the peak that 
is being analysed. 
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Promoter: 
Position 60: The blue line below denotes the region of difference between cases and control. 
The cases are present on the left side and controls on the right side. Two of the cases (CCR 
03 and CCR 48) are homozygous “A” for position 60 where as other cases are heterozygous 
“R: G/A”. All controls are homozygous “G” except for CCR30 which is heterozygous “R”. 
                  
 
 
Position 234: The cases on left, CCR48 and 3 are homozygous “C” whereas all other cases 
are heterozygous “Y”. The controls on right, CCR 30 and 14 are heterozygous “Y” whereas 
others are homozygous “T”. 
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Position 281: The cases on left, CCR48 and 03 are homozygous “T” and other are 
heterozygous “Y”. The controls on right, all controls are homozygous “C” except for CCR30 
that is heterozygous “Y”. 
    
 
 
Position 895: The cases on left, CCR48 and 03 are homozygous “G” whereas others are 
heterozygous “R”. The controls on right, all the controls are homozygous “A” except for 
CCR 30 that is heterozygous “R”. 
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Position 1023: The cases on left, CCR 48 and 03 are homozygous “A” and other cases are 
heterozygous “R”. The controls on right, controls CCR 30 and 14 are heterozygous “R” 
where as other controls are homozygous “G”. 
    
 
 
Position 1138: The cases on left, CCR48 and 03 are homozygous “A” and other cases are 
heterozygous “R”. The controls on right, controls CCR 30 and CCR 14 are heterozygous 
“R” and other controls are homozygous “G”. 
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Position 1333:  The controls on the bottom, all the controls have an insertion “T” except for 
CCR30. In cases on the top, CCR15, CCR 33 and CCR36 have insertion. CCR 15 and 
CCR33 are heterozygous “W: A/T” whereas CCR36 is homozygous “T” for insertion. 
CCR03 and CCR 48 don’t have any insertion in that position. 
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Exon 6: 
 
In above chromatogram, the position that differed is marked by a blue line that runs through the 
peaks. A case (CCR48) is homozygous for an allele “T” where as the control “CCR08” is 
homozygous for an allele “A”. 
 
 
In above chromatogram, Exon 6 sequences of four cases CCR-36, 33, 15 and 3 are analysed. Two 
of the cases 36 and 3 are homozygous “T” for that position whereas other cases are heterozygous 
“W: A/T”. 
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In above chromatogram, Exon 6 sequences of four controls CCR-33, 28, 27 and 14 are analysed. 
All of the controls are heterozygous “W: A/T” for that position. 
 
Exon 15: 
 
For Exon 15, in above chromatogram a case is homozygous for allele “C” and the control is 
homozygous for an allele “T”. 
 
 
In above chromatogram, Exon 15 sequences of four cases CCR-36, 33, 15 and 3 are analysed. 
Two of the cases 33 and 3 are heterozygous “Y: T/C” for that position, other case CCR33 is 
heterozygous “M: A/C” and CCR36 is homozygous “C”. 
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In above chromatogram, Exon 15 sequences of four controls CCR-36, 33, 15 and 3 are analysed. 
Two of the cases 28 and 27 are heterozygous “Y: T/C” for that position, other case CCR14 is 
heterozygous “M: A/C” and CCR30 is homozygous “T”. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
FEMALE : 
RETINOPATHY 
X: INDIVIDUALS MARKED WITH ‘X’ DENOTES THAT 
WE DON’T HAVE THEM IN OUR SAMPLE LIST. 
  
  
MALE : NORMAL    FEMALE : NORMAL  
    MALE : UNKNOWN 
VETERINARY DATA 
FEMALE : UNKNOWN 
VETERINARY DATA 
MALE : 
RETINOPATHY 
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 X  X  X  X  X 
  
2005 
 X 
2006 
       X  X  X 
 X  X 
2002 
 
 X 
 X  X 
 X  X  X  X  X 
2003 
 X 
2005 
 X  X  X 
2006 
 
Pedigree A A1 
~7 yrs 
~7 yrs 
~4 yrs 
~6 yrs 
~5 yrs 
~6 yrs ~6 yrs 
~6 yrs ~6 yrs ~6 yrs ~7 yrs 
2 yrs 
11m 
2 yrs 
11m 
3 yrs 
8m 
~5 yrs ~5 yrs 
~4yrs 
~3 yrs 
~9yrs  X 
 X  X  X   
~1yrs ~3yrs ~4yrs 
~5yrs 
2008 
 X 
 X  X  X 
~1yrs ~1yrs ~1yrs 
A2 
A3 
A4 
  
 
57 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
X  X 
   X  X 
 X 
2002 
 
 X 
2004 
 
 X  X 
 X  X 
 X 
 X  X 
 X 
 X 
 X 
 X 
 X  X 
 X  X  X  X 
1996 
 
 X 
2001 
 
  
 X 
 X 
1999 
 
1998 
 
 X  X  X  X 
2001 
 
 X  X  X  X 
 X  X  X  X 
2002 
 
2005 
 
 X  X   
 X 
 X  X  X 
2002 
 
 X  X  X  X   
2003 
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2006 
 
2006 
 
 X  X  X 
 X 
2006 
 
 X  X  X 
Pedigree B 
~12 yrs 
~8 yrs 
6 yrs 9m 
~6 yrs 6 yrs 2m 
~6 yrs 
~5 yrs ~5 yrs 
~5 yrs ~5 yrs 
5 yrs 2m 
~5 yrs 
~3 yrs 
~3 yrs 
~3 yrs 
~1 yrs 
~3 yrs 
~11 yrs 
~8 yrs 
~11 yrs 
~8 yrs 
~4 yrs ~5 yrs ~6 yrs ~6 yrs 
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B1 
B2 
B3 
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B5 
B6 
B7 
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~8 yrs 
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~10 yrs 
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Pedigree D 
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